Home Visit
Upload
Alzheimer Disease Screening Profile, CSF
Alzheimer Disease Screening Profile, CSF
52+ booked in last 3 days
No special precautions
Recommended for
Male, Female
Report
Within 48 Hours
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Alzheimer Test Overview
Alzheimer’s disease is the most common cause of dementia leading to a gradual decline in memory, thinking ability, cognitive skills and daily activities. This may in turn also affect the mood, behaviour and social skills of the patient. Alzheimer’s most commonly occurs beyond 65 years, although in certain rare cases, it may occur in patients <50 years (early-onset Alzheimer’s). The most common cause of Alzheimer’s is the deposition of certain proteins known as amyloid proteins in the brain cells. Alzheimer's disease screening profile analyzes cerebrospinal fluid (CSF) for protein levels. This profile measures beta-amyloid (1-42), a protein linked to Alzheimer's plaques, alongside total tau or phosphorylated tau (p-tau), which indicates neurodegeneration. The ratio of beta-amyloid (1-42) to beta-amyloid (1-40) can further refine the diagnosis, helping distinguish Alzheimer's from other forms of dementia like vascular dementia.
The Alzheimer test is a diagnostic tool to detect biomarkers linked to Alzheimer's disease, enabling early diagnosis and better management. Recent advancements include blood tests, like one detecting "brain-derived tau" (BD-tau), specific to Alzheimer's and correlating with cerebrospinal fluid markers. AIIMS, Delhi, has also developed a blood test identifying six markers that can predict the disease 10-15 years before symptoms appear. These non-invasive methods make screening more accessible, offering hope for slowing disease progression and improving care. Such breakthroughs are revolutionising early diagnosis and management of Alzheimer's disease.
Reasons for Undergoing the Alzheimer Test
Undergoing the Alzheimer test is crucial for several reasons:
- Early Detection: The Alzheimer test can identify Alzheimer's disease at an early stage, even before symptoms become apparent. This early detection allows for better management of symptoms and potentially slows down the disease progression.
- Differential Diagnosis: The Alzheimer test helps rule out other causes of memory loss and cognitive decline, ensuring a more accurate diagnosis.
- Family History: Individuals with a family history of Alzheimer's can benefit from genetic Alzheimer tests, such as the APOE gene test, to assess their risk.
- Carer Support: Early diagnosis through an Alzheimer test can ease the predicaments of carers by providing them with a clearer understanding of the patient's condition and how to manage it.
List of Parameters Considered During the Alzheimer Test
The parameters measured during the Alzheimer test vary depending on the type of test:
- BD-tau: A specific biomarker for Alzheimer's, indicating neurodegeneration; correlates with cerebrospinal fluid markers.
- Amyloid & Tau Proteins: Linked to Alzheimer's; blood tests measure their levels to detect plaques and tangles.
- APOE Gene Variant: Identifies genetic risk for Alzheimer’s type 2.
- Six Blood Markers: AIIMS test detects early Alzheimer’s.
Alzheimer Test Preparation
Preparations for the Alzheimer test are generally straightforward:
- Providing a detailed clinical and family history is crucial for accurate Alzheimer tests.
- Genetic counselling, including pedigree charts, may be needed for genetic tests like APOE.
- No fasting or special diet is required before Alzheimer blood tests.
- Labs like Metropolis Healthcare offer home sample collection for convenience.
Alzheimer Test Results & Interpretation
The results of the Alzheimer test need to be interpreted by a healthcare professional.
- Biomarker Levels: High levels of biomarkers such as BD-tau, amyloid, and tau proteins, as indicated by the Alzheimer test, suggest the presence of Alzheimer's disease. The levels can also indicate the stage of the disease.
- APOE Gene Variant: The presence of certain APOE gene variants, as detected by the genetic Alzheimer test, indicates an increased risk of developing Alzheimer's disease. However, it does not guarantee the development of the disease.
- Clinical Correlation: The Alzheimer test results must be correlated with clinical symptoms and other diagnostic tests to confirm the diagnosis. Mental status tests, neurological exams, and brain imaging may also be used in conjunction with the blood tests.
Home Collection for Alzheimer Test
Metropolis Healthcare offers a convenient home sample collection service for the Alzheimer test, ensuring a seamless experience for patients. A trained phlebotomist will visit your home to collect the blood sample, maintaining the highest standards of safety, hygiene, and sample handling. This service eliminates the need to visit a clinic or laboratory, making the Alzheimer test more accessible and comfortable for patients and their carers. With Metropolis Healthcare's commitment to delivering reliable and timely results, you can trust that your Alzheimer test will be processed efficiently, empowering you to take proactive steps in managing your health or that of your loved ones.
Alzheimer Disease Screening Profile, CSF Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Alzheimer Disease Screening Profile, CSF with a clear pricing structure.
The Alzheimer Disease Screening Profile, CSF Price in Mumbai is ₹ 13,250 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Alzheimer disease screening profile CSF measure levels of beta-amyloid protein and tau protein in the CSF sample.
- Although the provisional diagnosis of Alzheimer’s is majorly done based on the patient’s symptoms and radiological examination, the laboratory tests and CSF examination may further aid the diagnosis.
- The test may be done for early diagnosis of suspected Alzheimer's disease.
- To differentiate between Alzheimer’s induced dementia and vascular causes for dementia.
It is advised that patients with the following clinical signs and symptoms of Alzheimer’s should undergo testing for differential diagnosis:
- Memory loss or dementia (mainly recent or short term memory)
- Delayed thinking or processing skills
- Reduced cognition
- Difficulty reasoning and handling complex tasks.
- Language processing difficulties.
- Understanding visual form and space relationship.
- Changes in overall behavior and personality.
This test requires a CSF sample. A spinal needle is used and the patient's CSF sample is collected with the necessary aseptic precautions. Note: Sample collection is done by qualified healthcare providers within hospital or clinic settings. The lab is only responsible for the analysis and processing of the sample.
No special precautions are required.
The levels of beta-amyloid protein and tau protein in the CSF sample aids the diagnosis and to determine the prognosis.
Determination of beta-amyloid (1-42) with total tau or p-tau in the CSF supports early diagnosis of suspected Alzheimer's disease. The beta-amyloid (1-42)/beta-amyloid (1-40) ratio can improve the discrimination between Alzheimer's patients and vascular dementia.
- Alzheimer’s test
- CSF test for Alzheimer’s
The Alzheimer test is a diagnostic tool that detects biomarkers associated with Alzheimer's disease. It includes blood tests that measure brain-derived tau, amyloid and tau proteins, and genetic variants like the APOE gene, helping to identify the disease in its early stages.
Normal levels for the Alzheimer test vary based on the specific biomarker being tested. Generally, lower levels of biomarkers such as brain-derived tau, amyloid, and tau proteins are considered normal. The testing laboratory typically provides specific normal ranges for each biomarker.
An Alzheimer test is used to detect biomarkers associated with Alzheimer's disease, enabling early diagnosis, differential diagnosis, and better management of symptoms. It helps identify the disease before clinical symptoms become apparent, allowing for timely intervention and support.
The frequency of Alzheimer testing depends on individual risk factors and clinical recommendations. Generally, testing is recommended for individuals displaying symptoms of cognitive decline or those with a significant family history of Alzheimer's disease.
There is no specific time requirement for the Alzheimer test. However, it is usually advised based on the presence of clinical symptoms or as part of a preventive health checkup, especially for individuals over 60 years old or those experiencing cognitive impairments.
No, fasting is typically not required for the blood tests associated with the Alzheimer test. You can undergo the test without any specific dietary preparations.
Before getting an Alzheimer test, provide a detailed clinical history to your healthcare provider. For genetic tests, like the APOE gene test, you may need to undergo genetic counselling. Some labs offer home sample collection for convenience.
The Alzheimer test measures various biomarkers, including brain-derived tau, amyloid and tau proteins, and genetic variants such as the APOE gene. The AIIMS-developed test specifically measures six blood markers that indicate the early onset of Alzheimer's disease.
An Alzheimer test should be done when clinical symptoms suggest cognitive impairment, there is a family history of Alzheimer's, or as part of preventive health screening for individuals over 60 years old.
The blood draw for the Alzheimer test is quick and similar to any standard blood test. The overall process, including preparation and sample collection, is relatively straightforward and does not require a significant amount of time.
Reports for the Alzheimer test, such as the APOE gene test, are typically available within a week based on the day/time the sample was collected and processed.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp